Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin before embryo reduction to reduce abortion in multiple pregnancy
IRCT20190113042349N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of indomethacin in abortion (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Effect on abortion in embryo reduction operations. Started Jan 2019; status: completed.
02
Drugs
indomethacin
03
Conditions
abortion
Beyond the preview
Go deeper on IRCT20190113042349N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190113042349N1.